It is time to accelerate building local vaccine adjuvant manufacturing capacity.
作者信息
Fox Christopher B
机构信息
IDRI, 1616 Eastlake Avenue East, Suite 400, Seattle, WA 98102, USA.
出版信息
Ther Adv Vaccines Immunother. 2017 Dec;5(6):111-113. doi: 10.1177/2051013617733259. Epub 2017 Oct 9.
Abstract
摘要
相似文献
1
It is time to accelerate building local vaccine adjuvant manufacturing capacity.
Ther Adv Vaccines Immunother. 2017 Dec;5(6):111-113. doi: 10.1177/2051013617733259. Epub 2017 Oct 9.
2
Technology transfer of oil-in-water emulsion adjuvant manufacturing for pandemic influenza vaccine production in Romania: Preclinical evaluation of split virion inactivated H5N1 vaccine with adjuvant.
Hum Vaccin Immunother. 2016 Apr 2;12(4):1009-26. doi: 10.1080/21645515.2015.1111495. Epub 2015 Nov 30.
3
Technology transfer of oil-in-water emulsion adjuvant manufacturing for pandemic influenza vaccine production in Romania.
Vaccine. 2013 Mar 15;31(12):1633-40. doi: 10.1016/j.vaccine.2012.10.048. Epub 2012 Oct 25.
4
Technology transfer of an oil-in-water vaccine-adjuvant for strengthening pandemic influenza preparedness in Indonesia.
Vaccine. 2013 Mar 15;31(12):1641-5. doi: 10.1016/j.vaccine.2012.07.074. Epub 2012 Aug 8.
5
Lessons from pandemic influenza A(H1N1): the research-based vaccine industry's perspective.
Vaccine. 2011 Feb 1;29(6):1135-8. doi: 10.1016/j.vaccine.2010.11.042. Epub 2010 Nov 27.
6
Comprehensive hands-on training for influenza vaccine manufacturing: a WHO-BARDA-BTEC partnership for global workforce development.
Biochem Mol Biol Educ. 2014 Sep-Oct;42(5):414-9. doi: 10.1002/bmb.20817. Epub 2014 Aug 18.
7
WHO initiative to increase global and equitable access to influenza vaccine in the event of a pandemic: supporting developing country production capacity through technology transfer.
Vaccine. 2011 Jul 1;29 Suppl 1:A2-7. doi: 10.1016/j.vaccine.2011.02.079.
8
An international technology platform for influenza vaccines.
Vaccine. 2011 Jul 1;29 Suppl 1:A8-11. doi: 10.1016/j.vaccine.2011.04.124.
9
Challenges and successes for the grantees and the Technical Advisory Group of WHO's influenza vaccine technology transfer initiative.
Vaccine. 2016 Oct 26;34(45):5420-5424. doi: 10.1016/j.vaccine.2016.07.047. Epub 2016 Aug 6.
10
United States of America Department of Health and Human Services support for advancing influenza vaccine manufacturing in the developing world.
Vaccine. 2011 Jul 1;29 Suppl 1:A48-50. doi: 10.1016/j.vaccine.2011.02.080.
引用本文的文献
1
Vaccine technology transfer in a global health crisis: Actors, capabilities, and institutions.
Res Policy. 2023 May;52(4):104739. doi: 10.1016/j.respol.2023.104739. Epub 2023 Feb 8.
2
Better Pandemic Influenza Preparedness through Adjuvant Technology Transfer: Challenges and Lessons Learned.
Vaccines (Basel). 2021 May 5;9(5):461. doi: 10.3390/vaccines9050461.
3
Squalene Emulsion Manufacturing Process Scale-Up for Enhanced Global Pandemic Response.
Pharmaceuticals (Basel). 2020 Jul 28;13(8):168. doi: 10.3390/ph13080168.
本文引用的文献
1
Considerations for sustainable influenza vaccine production in developing countries.
Vaccine. 2016 Oct 26;34(45):5425-5429. doi: 10.1016/j.vaccine.2016.08.056. Epub 2016 Sep 7.
2
Challenges and successes for the grantees and the Technical Advisory Group of WHO's influenza vaccine technology transfer initiative.
Vaccine. 2016 Oct 26;34(45):5420-5424. doi: 10.1016/j.vaccine.2016.07.047. Epub 2016 Aug 6.
3
Technology transfer of oil-in-water emulsion adjuvant manufacturing for pandemic influenza vaccine production in Romania: Preclinical evaluation of split virion inactivated H5N1 vaccine with adjuvant.
Hum Vaccin Immunother. 2016 Apr 2;12(4):1009-26. doi: 10.1080/21645515.2015.1111495. Epub 2015 Nov 30.
4
Challenges and Opportunities While Developing a Group A Meningococcal Conjugate Vaccine Within a Product Development Partnership: A Manufacturer's Perspective From the Serum Institute of India.
Clin Infect Dis. 2015 Nov 15;61 Suppl 5(Suppl 5):S483-8. doi: 10.1093/cid/civ500.
5
Are we entering a new age for human vaccine adjuvants?
Expert Rev Vaccines. 2015 Jul;14(7):909-11. doi: 10.1586/14760584.2015.1043273. Epub 2015 May 6.
6
Key roles of adjuvants in modern vaccines.
Nat Med. 2013 Dec;19(12):1597-608. doi: 10.1038/nm.3409. Epub 2013 Dec 5.
7
Technology transfer of oil-in-water emulsion adjuvant manufacturing for pandemic influenza vaccine production in Romania.
Vaccine. 2013 Mar 15;31(12):1633-40. doi: 10.1016/j.vaccine.2012.10.048. Epub 2012 Oct 25.
8
Technology transfer of an oil-in-water vaccine-adjuvant for strengthening pandemic influenza preparedness in Indonesia.
Vaccine. 2013 Mar 15;31(12):1641-5. doi: 10.1016/j.vaccine.2012.07.074. Epub 2012 Aug 8.
9
Intellectual property, technology transfer and manufacture of low-cost HPV vaccines in India.
Nat Biotechnol. 2010 Jul;28(7):671-8. doi: 10.1038/nbt0710-671.
Zotero 插件